Key result
Transcriptional alterations were highly specific to individual genetic causes of cardiac hypertrophy in four transgenic mouse models, with no single gene consistently upregulated across all models.
Why the study?
Do different genetic causes of cardiac hypertrophy elicit divergent transcriptional responses in transgenic mouse models?
Population
Four different transgenic mouse hypertrophy models (protein kinase C-epsilon activation peptide…
Comparison
DNA microarray analyses using approximately… vs Comparison across the four different transgenic…
Design
Preclinical
Authors
Loading...
Hypothesis-generating for etiology-specific therapies in genetic hypertrophy; requires human validation before any clinical consideration.
Do different genetic causes of cardiac hypertrophy elicit divergent transcriptional responses in transgenic mouse models?
Different genetic causes of cardiac hypertrophy produce distinct transcriptional profiles rather than a single common gene program, suggesting the potential for condition-specific therapeutic approaches.
Aronow et al. (2001) studied Cardiac hypertrophy. Transgenic mouse hypertrophy models was evaluated on Gene expression profiles. Transcriptional alterations were highly specific to individual genetic causes of cardiac hypertrophy in four transgenic mouse models, with no single gene consistently upregulated across all models.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: